Xenetic Biosciences Inc (XBIO) — Cash Flow-to-Debt Ratio
Xenetic Biosciences Inc (XBIO) has a Cash Flow-to-Debt Ratio of -0.59x as of September 2025, meaning its operating cash flow of $-658.25K could theoretically repay -1% of its total liabilities ($1.11 Million) in one year. Check XBIO capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Xenetic Biosciences Inc Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Xenetic Biosciences Inc across 13 annual periods. Also explore Xenetic Biosciences Inc asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Xenetic Biosciences Inc (2012–2024)
Year-by-year debt coverage analysis for Xenetic Biosciences Inc. For market capitalisation and broader financial context, see Xenetic Biosciences Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.15x | $-2.82 Million | $894.26K | ▲ +38.0% |
| 2023 | -5.08x | $-4.11 Million | $809.59K | ▼ -17.4% |
| 2022 | -4.33x | $-4.65 Million | $1.07 Million | ▼ -29.9% |
| 2021 | -3.33x | $-4.74 Million | $1.42 Million | ▲ +24.7% |
| 2020 | -4.43x | $-4.27 Million | $963.97K | ▼ -199.8% |
| 2019 | -1.48x | $-6.40 Million | $4.33 Million | ▼ -3.2% |
| 2018 | -1.43x | $-6.46 Million | $4.52 Million | ▼ -565.5% |
| 2017 | 0.31x | $1.49 Million | $4.86 Million | ▲ +116.8% |
| 2016 | -1.83x | $-8.79 Million | $4.80 Million | ▼ -255.4% |
| 2015 | -0.51x | $-5.30 Million | $10.30 Million | ▲ +75.6% |
| 2014 | -2.11x | $-12.33 Million | $5.84 Million | ▼ -139.1% |
| 2013 | -0.88x | $-6.05 Million | $6.85 Million | ▲ +35.2% |
| 2012 | -1.36x | $-6.26 Million | $4.59 Million | — |